ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: All 77 New NCI Positions Go to Carcinogenesis Programs; “Not Wisest Way To Use Them” – Newell

February 4, 1977

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

Adamson, Henney Chair Silicone Task Force

April 25, 1992

NCI RFAs Available

May 5, 2000

Coalition Members Urged To Demand Intent Of Congress In Cancer Act Be Recognized

March 13, 1981

DFCI Puts The Cancer Letter On Its Intranet For Employees.

February 11, 2000